What is aTyr Pharma's cash ratio?

aTyr Pharma (ATYR) reported cash ratio of 0.9× in Q1 2026.

How has aTyr Pharma's cash ratio changed year-over-year?

aTyr Pharma's cash ratio decreased by 11.8% year-over-year, from 1× to 0.9×.

What is the long-term trend for aTyr Pharma's cash ratio?

Over 5 years (2020 to 2025), aTyr Pharma's cash ratio has grown at a -24.5% compound annual growth rate (CAGR), from 2.9× to 0.7×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

aTyr Pharma ATYR Cash ratio

Cash ratio at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

Merck & Co.MRK

0.2×-0.1×

United TherapeuticsUTHR

2.1×-0.5×

Design Therapeutics, Inc.DSGN

1.3×-0.4×

Vor BiopharmaVOR

10.6×+7.6×

Oric Pharmaceuticals, Inc.ORIC

3.2×+0.4×

Other financials

Income statement

See full

Revenue-—

Operating income-$11.4M+27.5%

Net income-$10.8M+27.5%

EPS (diluted)-$0.11+35.3%

Balance sheet

See full

Cash & equivalents$10.0M-3.4%

Total debt$12.3M-9.2%

Total equity$57.9M-22.8%

Total assets$79.7M-18.1%

Cash flow

See full

Operating cash flow-$12.5M+18.8%

CapEx$138.0K—

Free cash flow-$12.7M+17.9%

Valuation

See full

Market cap$54.88M-88.2%

Enterprise value$57.17M—

P/S288.8×—

Profitability

See full

Operating margin-40,856.3%+28,833pp

Net margin-39,009.5%+29,653pp

FCF margin-32,664.7%+4,018pp

Returns & leverage

See full

Return on equity-105.3%+50.6pp

Debt / equity0.2×0.0×

Current ratio5.8×-2.0×

Where this comes from

Calculated from aTyr Pharma’s reported figures.

cash and equivalents/total current liabilities=0.9×

Based on the most recent quarter.

The official record: aTyr Pharma’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about aTyr Pharma's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is aTyr Pharma's cash ratio?: aTyr Pharma (ATYR) reported cash ratio of 0.9× in Q1 2026.
How has aTyr Pharma's cash ratio changed year-over-year?: aTyr Pharma's cash ratio decreased by 11.8% year-over-year, from 1× to 0.9×.
What is the long-term trend for aTyr Pharma's cash ratio?: Over 5 years (2020 to 2025), aTyr Pharma's cash ratio has grown at a -24.5% compound annual growth rate (CAGR), from 2.9× to 0.7×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.